|
KMID : 0857020140290020135
|
|
Kosin Medical Journal
2014 Volume.29 No. 2 p.135 ~ p.140
|
|
|
Nerve-Sparing Cryoablation for the Treatment of Primary Prostate Cancer: the Preliminary Report
|
|
Choi Seong
|
|
|
Abstract
|
|
|
Background: To present a pilot study of nerve-sparing cryoablation for the treatment of primary prostate cancer.
Materials and Methods: Between 2008 and 2011, 9 patients underwent nerve-sparing cryoablation (unilateral 5, bilateral 4 patients). One neurovascular bundle (NVB) was spared on the side opposite the positive biopsy, and two NVBs were spared when indicated and possible. Just before the start of freezing, a 22-gauge spinal needle was placed into Denonvilliers fascia using a transperineal route, and normal saline was injected to separate the rectum from the prostate. The prostate-specific antigen (PSA) level was sampled every 3 months for the first 2 years and then every 6 months thereafter. Patients were considered to have a stable PSA if they had two consecutive PSA measurements without a rise.
Results: The follow-up was 40-months (19-66 months). All patients had stable PSA levels at last follow-up. Potency (defined as an erection sufficient to complete intercourse to the satisfaction of the patient) was maintained in 4 of 9 patients, 5 were potent with phosphodiesterase 5 inhibitors or intracavernosal injection.
Conclusions: Nerve-sparing cryoablation, in which one or two neurovascular bundle is spared, showed the possibility of preserving potency in most patients without compromising cancer control. These preliminary results warrant further study.
|
|
|
KEYWORD
|
|
|
Cancer, Cryoablation, Potency, Prostate
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|